These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12678252)

  • 21. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines.
    Coombes L; Stickings P; Tierney R; Rigsby P; Sesardic D
    J Immunol Methods; 2009 Oct; 350(1-2):142-9. PubMed ID: 19761770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed.
    Sesardic D; Winsnes R; Rigsby P; Tierney R; Gaines-Das R
    Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.
    Hendriksen CF
    Expert Rev Vaccines; 2009 Mar; 8(3):313-22. PubMed ID: 19249973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 25. Vero cell assay validation of an alternative to the Ph. Eur. diphtheria potency tests.
    Gommer AM
    Dev Biol Stand; 1996; 86():217-24. PubMed ID: 8785952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards eliminating the use of animals for regulatory required vaccine quality control.
    Hendriksen CF
    ALTEX; 2006; 23(3):187-90. PubMed ID: 17086348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U; Noeske K; Werner E
    ALTEX; 2005; 22(3):169-74. PubMed ID: 16186992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency testing of diphtheria and tetanus toxoids. A reliable, pragmatic and economic approach.
    Stainer DW
    Dev Biol Stand; 1996; 86():303-8. PubMed ID: 8785960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria.
    Piersma SJ; Leenaars MP; Guzylack-Piriou L; Summerfield A; Hendriksen CF; McCullough KC
    Vaccine; 2006 Apr; 24(16):3076-83. PubMed ID: 16504349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
    Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The results of study of pertussis component of DPT vaccine produced in USSR and some other countries.
    Zakharova MS; Malivanova OM; Sokolovskaya AD; Shavrova EN; Kapustik LA
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(4):439-48. PubMed ID: 7320507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of some proposals for a reduction in the number of animals used for the potency testing of diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    J Biol Stand; 1987 Apr; 15(2):165-75. PubMed ID: 3597449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 34. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
    Lensing HH; Behr-Gross ME; Daas A; Spieser JM
    Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WHO activities towards the three Rs in the development and control of biological products.
    Milstien J; Grachev V; Padilla A; Griffiths E
    Dev Biol Stand; 1996; 86():31-9. PubMed ID: 8785961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calibration of replacement international standards of diphtheria and tetanus toxoids for use in flocculation test.
    Preneta-Blanc R; Rigsby P; Wilhelmsen ES; Tierney R; Brierley M; Sesardic D
    Biologicals; 2008 Sep; 36(5):315-26. PubMed ID: 18676158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calibration of replacement international standard and European Pharmacopoeia Biological Reference Preparation for Diphtheria Toxoid, Adsorbed.
    Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
    Biologicals; 2001 Jun; 29(2):107-22. PubMed ID: 11580215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are potency tests for tetanus vaccines really necessary?
    Knight PA
    Dev Biol Stand; 1986; 64():39-45. PubMed ID: 3792656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.